Carrie Pistenmaa, MD
NPI 1619136231 · Pulmonary Disease Physician · Boston, MA
Enrolled with Medicare as Practitioner - Pulmonary Disease · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Carrie Pistenmaa, MD is a Pulmonary Disease Physician provider in Boston, MA (NPI 1619136231).
Provider details
- NPI number
- 1619136231
- Entity type
- Individual
- Primary specialty
- Pulmonary Disease PhysicianAllopathic & Osteopathic Physicians
- Credential
- MD
- Sex
- Female
- Sole proprietor
- No
- License
- 274146 (MA)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
18 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
583 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Test to Measure Expiratory Airflow and Volume94010 | 109 | $8 |
| Test to Examine How Well the Lungs Exchange Gases94729 | 93 | $9 |
| Test to Measure Expiratory Airflow and Volume94010 | 84 | $30 |
| Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 35 Minutes99232 | 69 | $81 |
| Test to Determine Lung Volumes Using Sensors94726 | 59 | $12 |
| Test to Measure Expiratory Airflow and Volume Changes Before and After Medication Administration94060 | 45 | $11 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 17 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Fluticasone/Umeclidin/Vilanterbrand: Trelegy Ellipta | 73 | 12 |
| Albuterol Sulfatebrand: Albuterol Sulfate Hfa | 53 | 21 |
| Umeclidinium Bromidebrand: Incruse Ellipta | 41 | — |
| Fluticasone/Vilanterolbrand: Breo Ellipta | 37 | — |
| Tiotropium Bromidebrand: Spiriva Respimat | 36 | — |
| Roflumilast | 34 | — |
Practice location
Mailing address
Registry dates
- Enumerated
- 2008-06-09
- Last updated
- 2022-09-14
- Certified
- 2022-09-14
Frequently asked questions
- What is Carrie Pistenmaa's NPI number?
- Carrie Pistenmaa's National Provider Identifier (NPI) is 1619136231, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Carrie Pistenmaa's specialty?
- Carrie Pistenmaa is listed in the NPPES registry with a primary specialty of Pulmonary Disease Physician (Allopathic & Osteopathic Physicians).
- Where is Carrie Pistenmaa located?
- Carrie Pistenmaa's practice location on file with NPPES is 75 Francis St, Boston, MA 02115-6106.
- What is Carrie Pistenmaa's phone number?
- The practice phone number listed in the NPPES registry for Carrie Pistenmaa is (617) 732-6770.
- Does Carrie Pistenmaa accept Medicare?
- Carrie Pistenmaa is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Carrie Pistenmaa's NPI active?
- Yes — Carrie Pistenmaa's NPI (1619136231) is active in the NPPES registry as of the last update on 2022-09-14.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.